Korean J Clin Microbiol.  2006 Apr;9(1):1-6.

In Vitro Activity of Antimicrobial Combination against Multidrug-Resistant Pseudomonas aeruginosa, Korea

Affiliations
  • 1Labgenomics Clinical Laboratories, 1571-17, Seocho 3-dong, Seocho-gu, Seoul, Korea. js1345@hitel.net
  • 2Department of Clinical Pathology, Mokdong Hospital,College of Medicine, Ewha Womans University, Seoul, Korea.

Abstract

BACKGROUND: Pseudomonas aeruginosafrequently causes nosocomial infection. Recently, there have been reports of infection with multidrug-resistant P. aeruginosa. The purpose of this study was to evaluate the in vitro effect of antimicrobial combination against multidrug-resistant P. aeruginosa.
METHODS
Twenty isolates of imipenem and/or cefepime resistant P. aeruginosa were collected from the microbiology laboratory of Ewha Womans Unversity Mokdong Hospital. Checkerboard titration method was used to assess the activity of ceftazidime or cefepime in combination with amikacin, gentamicin or aztreonam, and colistin in combination with ceftazidime or rifampin.
RESULTS
All isolates were resistant to more than 12 antimicrobial agents including imipenem and/or cefepime by broth microdilution method; however, no isolates were resistant to colistin. Most of the isolates showed high level resistance to ceftazidime, cefepime and meropenem, with MIC90 of 128, 512 and 64 microgram/mL, respectively. The MIC90 of colistin was 2 microgram/mL, which is within the su ceptiblerange. Synergistic effect was not detected by the checkerboard titration method with any antimicrobial combinations. However, a partial synergy was observed in 40% of the isolates with the combination of ceftazidime and amikacin, 65% with ceftazidime and gentamicin, 45% with cefepime and amikacin, and 75% with cefepime and gentamicin. Other antimicrobial combinations showed indifference against most strains, and antagonism was not observed.
CONCLUSION
Multidrug-resistant P. aeruginosa isolates were all susceptible to colistin. The combined regimens of ceftazidime with amikacin or gentamicin and cefepime with amikacin or gentamicin revealed a partially synergistic effect in 40-75% of the isolates.

Keyword

Pseudomonas aeruginosa; Antimicrobial combination; Synergy

MeSH Terms

Amikacin
Anti-Infective Agents
Aztreonam
Ceftazidime
Colistin
Cross Infection
Female
Gentamicins
Humans
Imipenem
Korea*
Pseudomonas aeruginosa*
Pseudomonas*
Rifampin
Amikacin
Anti-Infective Agents
Aztreonam
Ceftazidime
Colistin
Gentamicins
Imipenem
Rifampin
Full Text Links
  • KJCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr